| 000 | 01294 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515072455.0 | ||
| 264 | 0 | _c20070925 | |
| 008 | 200709s 0 0 jpn d | ||
| 022 | _a0021-4930 | ||
| 024 | 7 |
_a10.3412/jsb.62.271 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKamiya, Shigeru | |
| 245 | 0 | 0 |
_a[Helicobacter pylori infection and probiotics]. _h[electronic resource] |
| 260 |
_bNihon saikingaku zasshi. Japanese journal of bacteriology _cMay 2007 |
||
| 300 |
_a271-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aAmoxicillin _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBifidobacterium |
| 650 | 0 | 4 |
_aClarithromycin _xtherapeutic use |
| 650 | 0 | 4 | _aClostridium butyricum |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHelicobacter Infections _xmicrobiology |
| 650 | 0 | 4 | _aHelicobacter pylori |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLactobacillus |
| 650 | 0 | 4 | _aLansoprazole |
| 650 | 0 | 4 |
_aProbiotics _xadverse effects |
| 650 | 0 | 4 | _aSaccharomyces |
| 773 | 0 |
_tNihon saikingaku zasshi. Japanese journal of bacteriology _gvol. 62 _gno. 2 _gp. 271-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3412/jsb.62.271 _zAvailable from publisher's website |
| 999 |
_c17113560 _d17113560 |
||